Takenori Niioka

Summary

Affiliation: University of Tokyo
Country: Japan

Publications

  1. pmc Pharmacokinetics of dasatinib for Philadelphia-positive acute lymphocytic leukemia with acquired T315I mutation
    Naoto Takahashi
    Dept of Hematology Nephrology and Rheumatology, Akita Univ Graduate School of Medicine, Akita, Japan
    J Hematol Oncol 5:23. 2012
  2. ncbi request reprint Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors
    Takenori Niioka
    Department of Pharmacy, Hirosaki University Hospital
    Yakugaku Zasshi 131:407-13. 2011
  3. ncbi request reprint Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma
    Takenori Niioka
    Department of Pharmacy, Hirosaki University Hospital, Hirosaki 036 8563, Japan
    Cancer Chemother Pharmacol 59:575-80. 2007
  4. ncbi request reprint Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve
    Takenori Niioka
    Department of Pharmacy, Hirosaki University Hospital, Hirosaki, Japan
    Eur J Clin Pharmacol 62:855-61. 2006
  5. doi request reprint Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers
    Takenori Niioka
    Department of Pharmacy, Hirosaki University Hospital, Aomori, Japan
    Eur J Clin Pharmacol 64:503-9. 2008
  6. doi request reprint Early phase limited sampling strategy characterizing tacrolimus and mycophenolic acid pharmacokinetics adapted to the maintenance phase of renal transplant patients
    Masatomo Miura
    Department of Pharmacy, Akita University Hospital, Akita, Japan
    Ther Drug Monit 31:467-74. 2009
  7. doi request reprint Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation
    Takenori Niioka
    Department of Pharmacy, Akita University School of Medicine, Akita, Japan
    Transplantation 94:1013-9. 2012
  8. doi request reprint Monitoring of mycophenolic acid predose concentrations in the maintenance phase more than one year after renal transplantation
    Masatomo Miura
    Department of Pharmacy, Akita University Hospital, and Department of Urology, Akita University School of Medicine, Akita, Japan
    Ther Drug Monit 33:295-302. 2011
  9. ncbi request reprint Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration
    Takenori Niioka
    Department of Pharmacy, Hirosaki University Hospital, Hirosaki, Japan
    Eur J Clin Pharmacol 63:1031-8. 2007
  10. doi request reprint A limited sampling strategy to estimate the area under the concentration-time curve of tacrolimus modified-release once-daily preparation in renal transplant recipients
    Takenori Niioka
    Department of Pharmacy, Akita University Hospital, Akita, Japan
    Ther Drug Monit 35:228-32. 2013

Collaborators

Detail Information

Publications23

  1. pmc Pharmacokinetics of dasatinib for Philadelphia-positive acute lymphocytic leukemia with acquired T315I mutation
    Naoto Takahashi
    Dept of Hematology Nephrology and Rheumatology, Akita Univ Graduate School of Medicine, Akita, Japan
    J Hematol Oncol 5:23. 2012
    ..Despite the potent inhibition of BCR-ABL kinase by dasatinib, little is known about the relationship between dasatinib pharmacokinetics and the emergence of kinase domain mutations in vivo...
  2. ncbi request reprint Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors
    Takenori Niioka
    Department of Pharmacy, Hirosaki University Hospital
    Yakugaku Zasshi 131:407-13. 2011
    ..Those strategies, plasma concentration monitoring at one or two time-points, might be more suitable for AUC estimation than reference to CYP2C19 genotypes, particularly in the case of coadministration of CYP mediators...
  3. ncbi request reprint Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma
    Takenori Niioka
    Department of Pharmacy, Hirosaki University Hospital, Hirosaki 036 8563, Japan
    Cancer Chemother Pharmacol 59:575-80. 2007
    ..We also evaluated predictive accuracy of reported formulas to estimate the area under the plasma concentration-time curve (AUC) of low-dose nedaplatin...
  4. ncbi request reprint Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve
    Takenori Niioka
    Department of Pharmacy, Hirosaki University Hospital, Hirosaki, Japan
    Eur J Clin Pharmacol 62:855-61. 2006
    ..The purpose of this study is to evaluate whether a simple formula using limited blood samples can predict the area under the plasma rabeprazole concentration-time curve (AUC) in co-administration with CYP inhibitors...
  5. doi request reprint Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers
    Takenori Niioka
    Department of Pharmacy, Hirosaki University Hospital, Aomori, Japan
    Eur J Clin Pharmacol 64:503-9. 2008
    ..The purpose of this study was to identify the common time point that gives plasma concentrations of lansoprazole enantiomers that adequately reflect the AUC of racemic lansoprazole...
  6. doi request reprint Early phase limited sampling strategy characterizing tacrolimus and mycophenolic acid pharmacokinetics adapted to the maintenance phase of renal transplant patients
    Masatomo Miura
    Department of Pharmacy, Akita University Hospital, Akita, Japan
    Ther Drug Monit 31:467-74. 2009
    ..It is important that the LSS includes C 9h because it contains information on the secondary plasma peak of MPA...
  7. doi request reprint Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation
    Takenori Niioka
    Department of Pharmacy, Akita University School of Medicine, Akita, Japan
    Transplantation 94:1013-9. 2012
    ....
  8. doi request reprint Monitoring of mycophenolic acid predose concentrations in the maintenance phase more than one year after renal transplantation
    Masatomo Miura
    Department of Pharmacy, Akita University Hospital, and Department of Urology, Akita University School of Medicine, Akita, Japan
    Ther Drug Monit 33:295-302. 2011
    ..Routine therapeutic drug monitoring of mycophenolic acid (MPA) is generally performed using the area under the concentration-time curve from 0 to 12 hours (AUC0-12) with recommended values between 30 and 60 μg·h/mL...
  9. ncbi request reprint Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration
    Takenori Niioka
    Department of Pharmacy, Hirosaki University Hospital, Hirosaki, Japan
    Eur J Clin Pharmacol 63:1031-8. 2007
    ....
  10. doi request reprint A limited sampling strategy to estimate the area under the concentration-time curve of tacrolimus modified-release once-daily preparation in renal transplant recipients
    Takenori Niioka
    Department of Pharmacy, Akita University Hospital, Akita, Japan
    Ther Drug Monit 35:228-32. 2013
    ....
  11. doi request reprint Influence of CYP2C19 and ABCB1 polymorphisms on plasma concentrations of lansoprazole enantiomers after enteral administration
    Masatomo Miura
    Department of Pharmacy, Akita University Hospital, Akita, Japan
    Xenobiotica 40:630-6. 2010
    ..With enteral administration, CYP2C19 phenotyping of patients using the lansoprazole R/S enantiomer index at C(4h) could be possible...
  12. ncbi request reprint Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve
    Takenori Niioka
    Department of Pharmacy, Hirosaki University School of Medicine, Hirosaki, Japan
    Ther Drug Monit 28:321-5. 2006
    ..This method of plasma concentration monitoring at one time-point might be more suitable for AUC estimation than reference to CYP2C19 genotypes, particularly in coadministration of CYP mediators...
  13. pmc Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients
    Hideaki Kagaya
    Department of Pharmacy, Akita University Hospital, Akita, Japan
    Antimicrob Agents Chemother 56:825-9. 2012
    ..Further studies with a larger sample size should be able to clarify the relationship between SMX plasma concentration and side effects...
  14. doi request reprint Pharmaceutical and genetic determinants for interindividual differences of tacrolimus bioavailability in renal transplant recipients
    Takenori Niioka
    Department of Pharmacy, Akita University Hospital, 1 1 1 Hondo, Akita, 010 8543, Japan
    Eur J Clin Pharmacol 69:1659-65. 2013
    ..We investigated factors affecting interindividual variability of tacrolimus bioavailability in renal transplant patients...
  15. doi request reprint Correlation between R/S enantiomer ratio of lansoprazole and CYP2C19 activity after single oral and enteral administration
    Masatomo Miura
    Department of Pharmacy, Akita University Hospital, Akita, Japan
    Chirality 22:635-40. 2010
    ..70 and (S)-lansoprazole concentration at 4 h > or = 50 ng/ml...
  16. ncbi request reprint Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations
    Tsukasa Uno
    Department of Clinical Pharmacology, Hirosaki University School of Medicine, Hirosaki, Japan
    Eur J Clin Pharmacol 63:143-9. 2007
    ..The aim of this study was to evaluate the absolute bioavailability and the metabolism of omeprazole following single intravenous and oral administrations to healthy subjects in relation to CYP2C19 genotypes...
  17. ncbi request reprint Simultaneous determination of warfarin enantiomers and its metabolite in human plasma by column-switching high-performance liquid chromatography with chiral separation
    Tsukasa Uno
    Department of Clinical Pharmacology, Hirosaki University School of Medicine, Hirosaki, Japan
    Ther Drug Monit 29:333-9. 2007
    ....
  18. doi request reprint Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers
    Junji Saruwatari
    Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan
    J Clin Psychopharmacol 32:195-9. 2012
    ....
  19. doi request reprint Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients
    Masatomo Miura
    Department of Pharmacy, Akita University Hospital, Akita, Japan
    Ther Drug Monit 30:52-9. 2008
    ..In addition, a limited sampling strategy using C0h-C2h-C4h is recommended for the simultaneous estimation of the AUC0-12 of tacrolimus and MPA when focused on samples collected within 4 hours after administration for clinical expediency...
  20. ncbi request reprint Effect of itraconazole on pharmacokinetics of paroxetine: the role of gut transporters
    Norio Yasui-Furukori
    Department of Neuropsychiatry Hirosaki University School of Medicine, Hirosaki, Japan
    Ther Drug Monit 29:45-8. 2007
    ..05), the alteration was small (1.1 fold). The present study demonstrated that the bioavailability of paroxetine was increased by itraconazole, suggesting a possible involvement of P-glycoprotein in the pharmacokinetics of paroxetine...
  21. ncbi request reprint Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects
    Norio Yasui-Furukori
    Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki 036 8562, Japan
    Eur J Clin Pharmacol 63:51-6. 2007
    ..The aim of this study was to examine the effects of terbinafine, a potent inhibitor of CYP2D6, on pharmacokinetics of paroxetine...
  22. ncbi request reprint Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes
    Mikiko Shimizu
    Department of Clinical Pharmacology, Hirosaki University School of Medicine, Hirosaki 036 8562, Japan
    J Chromatogr B Analyt Technol Biomed Life Sci 832:241-8. 2006
    ..The limits of quantification were 3 ng/ml for omeprazole and its metabolites. This method was suitable for use in pharmacokinetic studies in human volunteers, and provides a useful tool for measuring CYP2C19 activity...
  23. ncbi request reprint Different serum concentrations of steady-state valproic acid in two sustained-release formulations
    Norio Yasui-Furukori
    Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan
    Psychiatry Clin Neurosci 61:308-12. 2007
    ..When a prescription for valproic acid is switched from one drug to the other, prescribers should be aware that the therapeutic drug monitoring data are not consistent...